MLKL (E7V4W) Mouse Monoclonal Antibody (BSA and Azide Free)#44621,Cell Signaling Technology (CST),44621

Necroptosis, a regulated pathway for necrotic cell death, is triggered by a number of inflammatory signals including cytokines in the tumor necrosis factor (TNF) family, pathogen sensors such as toll-like receptors (TLRs), and ischemic injury (1,2). The process is negatively regulated by caspases and is initiated through a complex containing the RIP1 and RIP3 kinases, typically referred to as the necrosome. Mixed lineage kinase domain-like protein (MLKL) is a pseudokinase that was identified as a downstream target of RIP3 in the necroptosis pathway (3,4). During necroptosis RIP3 is phosphorylated at Ser227, which recruits MLKL and leads to its phosphorylation at Thr357 and Ser358 (3). Knockdown of MLKL through multiple mechanisms results in inhibition of necroptosis (3-5). While the precise mechanism for MLKL-induced necroptosis is unclear, some studies have shown that necroptosis leads to oligomerization of MLKL and translocation to the plasma membrane, where it affects membrane integrity (6-9).Christofferson, D.E. and Yuan, J. (2010)Curr Opin Cell Biol22, 263-8.Kaczmarek, A. et al. (2013)Immunity38, 209-23.Sun, L. et al. (2012)Cell148, 213-27.Wang, Z. et al. (2012)Cell148, 228-43.Wu, J. et al. (2013)Cell Res23, 994-1006.Cai, Z. et al. (2014)Nat Cell Biol16, 55-65.Chen, X. et al. (2014)Cell Res24, 105-21.Wang, H. et al. (2014)Mol Cell54, 133-46.Dondelinger, Y. et al. (2014)Cell Rep7, 971-81.Alternate NamesFLJ34389; hMLKL; mixed lineage kinase domain like pseudokinase; mixed lineage kinase domain-like; Mixed lineage kinase domain-like protein; MLKL

FLJ34389; hMLKL; mixed lineage kinase domain like pseudokinase; mixed lineage kinase domain-like; Mixed lineage kinase domain-like protein; MLKL